Page 80 - 75_03
P. 80
ANA M.a PASCUAL-LEONE PASCUAL
73. Ragin, R. C., Donahoe, P. K. et al. (1992) Human Müllerian inhibiting subs-
tance enhanced purification imparts biochemical stability and restores anti-
proliferative effects. Protein. Expression. Purif. 3: 236-245.
74. Chin, T., Parry, R. L. & Donahoe, P. K. (1991) Human anti-Müllerian inhibi-
ting substance inhibits tumor growth in vitro e in vivo. Cancer Res. 51: 2101-
2106.
75. Rey, R. A., Lhomme, C., Marcillac, I. et al. (1996) Anti-Müllerian hormone as
a serum marker of granulosa cell tumours of the ovary, comparative study
with serum á-inhibin and estradiol. Am. J. Obstet. Gynecol. 174: 958-65.
76. Rey, R. A., Sabourin, J. C. et al. (2000) Anti-Müllerian hormone is a specific
marker of Sertoli and granulosa cell origin in gonadal tumours. Hum. Pathol.
31: 1202-8.
77. Rey, R. A., Bellville, C., Nihoul–Fekete, C. et al. (1999) Evaluation of gonadal
function in 107 intersex patients by means of serum anti-Müllerian hormone
measurement. J. Clin. Endocrinol. Metab. 64: 627-31.
78. Al-Qahtani, A. & Groome, N. P. (2006) Anti-Mullerian hormone: Cinderella
finds new admirers. J. Clin. Endocrinol. Metab. 91 (10), Editorial: 3760-3752.
79. García Segura, L. M. (1996) Mecanismos celulares de la diferenciación sexual
del cerebro, en Hormonas, Instintos y Emociones, dirigida por Botella Lusiá,
J., JAF Tresguerres. Curso de Verano de El Escorial. Editorial de la Universi-
dad Complutense.
80. Cuezva, J. M., Pascual-Leone, A. M. & Patel, M. S. edts. (1990) Endocrine and
Biochemical Development of the Fetus and Neonate. Publicación de ponencias
del Annual Meeting of the Perinatal Biochemical Group of the Spanish Bio-
chemistry Society on Biochemical Development of the Fetus and Neonate, 15-
18 diciembre 1988, Madrid. Organizadores: Cuezva, J. M. y Pascual-Leone, A.
M., subvencionado por la Fundación Ramón Areces. Plenum Press New York.
* Información de contacto:
Doctora Ana M.ª Pascual-Leone Pascual.
Académica de Número y Vicepresidenta de la Real Academia Nacional de Farmacia.
C/ Torrelaguna, 125-3.º D.
28043 Madrid.
Email: apl@ranf.com
466
